These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27483082)

  • 1. Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.
    Samadder NJ; Neklason DW; Burt RW
    JAMA; 2016 Aug; 316(5):545. PubMed ID: 27483082
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulindac and Erlotinib for Familial Adenomatous Polyposis.
    Matuchansky C
    JAMA; 2016 Aug; 316(5):544-5. PubMed ID: 27483077
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
    Samadder NJ; Neklason DW; Boucher KM; Byrne KR; Kanth P; Samowitz W; Jones D; Tavtigian SV; Done MW; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Davis R; Topham MK; Lynch P; Strait E; McKinnon W; Burt RW; Kuwada SK
    JAMA; 2016 Mar 22-29; 315(12):1266-75. PubMed ID: 27002448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac plus erlotinib for familial adenomatous polyposis.
    Baker H
    Lancet Oncol; 2016 May; 17(5):e183. PubMed ID: 27051970
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of sulindac on small polyps in familial adenomatous polyposis.
    Debinski HS; Trojan J; Nugent KP; Spigelman AD; Phillips RK
    Lancet; 1995 Apr; 345(8953):855-6. PubMed ID: 7898240
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
    Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW
    JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.
    Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK
    Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.
    Seow-Choen F; Vijayan V; Keng V
    Br J Surg; 1996 Dec; 83(12):1763-6. PubMed ID: 9038563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
    Samadder NJ; Foster N; McMurray RP; Burke CA; Stoffel E; Kanth P; Das R; Cruz-Correa M; Vilar E; Mankaney G; Buttar N; Thirumurthi S; Turgeon DK; Sossenheimer M; Westover M; Richmond E; Umar A; Della'Zanna G; Rodriguez LM; Szabo E; Zahrieh D; Limburg PJ
    Gut; 2023 Feb; 72(2):256-263. PubMed ID: 35636921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Adenomatous Polyposis; Succesful Use of Sirolimus.
    Yuksekkaya H; Yucel A; Gumus M; Esen H; Toy H
    Am J Gastroenterol; 2016 Jul; 111(7):1040-1. PubMed ID: 27356835
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
    Delker DA; Wood AC; Snow AK; Samadder NJ; Samowitz WS; Affolter KE; Boucher KM; Pappas LM; Stijleman IJ; Kanth P; Byrne KR; Burt RW; Bernard PS; Neklason DW
    Cancer Prev Res (Phila); 2018 Jan; 11(1):4-15. PubMed ID: 29109117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomas of the ampulla of vater in familial adenomatous polyposis: Christian Theodore responds.
    Theodore C
    Gastroenterology; 2004 Feb; 126(2):628-9. PubMed ID: 14765399
    [No Abstract]   [Full Text] [Related]  

  • 14. Macroscopic and histologic regression of duodenal polyposis with FOLFOX4 chemotherapy for an ileal pouch adenocarcinoma in a patient with familial adenomatous polyposis.
    Pioche M; Aguero Garcete G; Forestier J; Lépilliez V; Nozières C; Lombard-Bohas C; Saurin JC
    Endoscopy; 2012 Dec; 44(12):1165-7. PubMed ID: 23188666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis.
    Klein WA; Miller HH; Anderson M; DeCosse JJ
    Cancer; 1987 Dec; 60(12):2863-8. PubMed ID: 2824015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis.
    Wallace MH; Forbes A; Beveridge IG; Spigelman AD; Hewer A; Venitt S; Phillips RK
    Dis Colon Rectum; 2001 Nov; 44(11):1585-9. PubMed ID: 11711728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
    Friederich P; Verschuur J; van Heumen BW; Roelofs HM; Berkhout M; Nagtegaal ID; van Oijen MG; van Krieken JH; Peters WH; Nagengast FM
    Int J Colorectal Dis; 2011 May; 26(5):575-82. PubMed ID: 21243500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Predicators of Duodenal Familial Adenomatous Polyposis Chemoprevention: Do Chemopreventive Drugs Hit Their Presumed Molecular Targets?
    Shureiqi I
    Cancer Prev Res (Phila); 2018 Jan; 11(1):1-3. PubMed ID: 29263155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema Nodosum-like Eruption in the Setting of Sorafenib Therapy.
    Coleman EL; Cowper SE; Stein SM; Leventhal JS
    JAMA Dermatol; 2018 Mar; 154(3):369-370. PubMed ID: 29453869
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of FAP with sulindac.
    Meyskens FL
    Curr Oncol Rep; 2002 Nov; 4(6):463. PubMed ID: 12385292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.